Purevax RCP FeLV Unione Europea - italiano - EMA (European Medicines Agency)

purevax rcp felv

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - prodotti immunologici per felidae, - gatti - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Purevax RCPCh FeLV Unione Europea - italiano - EMA (European Medicines Agency)

purevax rcpch felv

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97), attenuated chlamydophila felis (905 strain) - prodotti immunologici per felidae, - gatti - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against chlamydophila felis infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the chlamydiosis and feline leukaemia components, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

GENABILIN Italia - italiano - Ministero della Salute

genabilin

boehringer ingelheim vetmedica gmbh - menbutone - menbutone - 100 milligrammo (i), menbutone - 100 mg - menbutone

UBROLEXIN Italia - italiano - Ministero della Salute

ubrolexin

boehringer ingelheim vetmedica gmbh - cefalexina - cefalexina - 200 mg - cefalexin, combinations with other antibacterials

MAMYZIN A Italia - italiano - Ministero della Salute

mamyzin a

boehringer ingelheim vetmedica gmbh - benetaminpenicillina, penetamato iodidrato, framicetina solfato - benetaminpenicillina - 280 milligrammo (i); penetamato iodidrato - 100 milligrammo (i); framicetina solfato - 100 milligrammo (i), benetaminpenicillina - 280 milligrammo (i); framicetina solfato - 100 milligrammo (i); penetamato iodidrato - 100 milligrammo (i), penetamato iodidrato - 100 mg; benetaminpenicillina - 280 mg; framicetina solfato - 100 mg, benetaminpenicillina - 280 mg; framicetina solfato - 100 mg; penetamato iodidrato - 100 mg - benzylpenicillin, combinations with other antibacterials

MAMYZIN Italia - italiano - Ministero della Salute

mamyzin

boehringer ingelheim vetmedica gmbh - penetamato iodidrato - penetamato iodidrato - 10 grammo (i), penetamato iodidrato - 10 g, penetamato iodidrato - 5 g - penethamate hydroiodide

ProZinc Unione Europea - italiano - EMA (European Medicines Agency)

prozinc

boehringer ingelheim vetmedica gmbh - insulin human - insuline ed analoghi per iniezione, intermedio effetto - cats; dogs - per il trattamento del diabete mellito in cani e gatti per ottenere una riduzione dell'iperglicemia e del miglioramento dei segni clinici associati.

MONZAL Italia - italiano - Ministero della Salute

monzal

boehringer ingelheim vetmedica gmbh - profenveramina cloridrato - profenveramina cloridrato - 100 mg - vetrabutin

SEDIVET Italia - italiano - Ministero della Salute

sedivet

boehringer ingelheim vetmedica gmbh - romifidina cloridrato - romifidina cloridrato - 10 mg - romifidine

QUENTAN Italia - italiano - Ministero della Salute

quentan

boehringer ingelheim vetmedica gmbh - bromexina cloridrato - bromexina cloridrato - 3 milligrammo (i), bromesina cloridrato - 3 mg, bromessina cloridrato - 3 mg - bromhexine